Cargando…

Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study

BACKGROUND: Hypofractionated three-dimensional conformal radiation therapy (3D-CRT) is a treatment option for patients with early-stage non-small cell lung cancer (NSCLC) who are medically unable to tolerate surgery and who are not amenable to treatment with stereotactic body radiotherapy. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakaguchi, Masakuni, Maebayashi, Toshiya, Aizawa, Takuya, Ishibashi, Naoya, Fukushima, Shoko, Abe, Osamu, Saito, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717614/ https://www.ncbi.nlm.nih.gov/pubmed/26781290 http://dx.doi.org/10.1186/s13014-016-0582-1

Ejemplares similares

Successful radiotherapy in postoperative recurrence of a primary mediastinal yolk sac tumor: A case report
por: Sakaguchi, Masakuni, et al.
Publicado: (2015)

Docetaxel-induced radiation recall dermatitis with atypical features: A case report
por: Sakaguchi, Masakuni, et al.
Publicado: (2018)

Successful Pregnancy and Delivery After Radiation With Ovarian Shielding for Acute Lymphocytic Leukemia Before Menarche
por: Ishibashi, Naoya, et al.
Publicado: (2015)

Reasons for discontinuation of radiation therapy and effective countermeasures
por: Maebayashi, Toshiya, et al.
Publicado: (2018)

Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer
por: Sakaguchi, Masakuni, et al.
Publicado: (2021)

Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer
por: Ishibashi, Naoya, et al.
Publicado: (2017)

Is pectus excavatum a risk factor for radiation‐induced lung disease in patients undergoing radiation therapy following breast‐conserving surgery?
por: Ishibashi, Naoya, et al.
Publicado: (2018)

Organizing pneumonia after thoracic radiotherapy followed by anti‐PD‐1 antibody treatment for patients with lung cancer: Three case reports
por: Sakaguchi, Masakuni, et al.
Publicado: (2019)

Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levels
por: Ishibashi, Naoya, et al.
Publicado: (2022)

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
por: Aizawa, Takuya, et al.
Publicado: (2023)

Factors Predicting Late Rectal Disorders after Radiation Therapy for Prostate Cancer
por: Maebayashi, Toshiya, et al.
Publicado: (2017)

Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature
por: Maebayashi, Toshiya, et al.
Publicado: (2015)

A long-surviving patient with advanced esophageal basaloid squamous cell carcinoma treated only with radiotherapy: case report and literature review
por: Maebayashi, Toshiya, et al.
Publicado: (2017)

Radiation therapy for vaginal cancer in complete uterine prolapse with intrauterine adhesion: a case report
por: Ishibashi, Naoya, et al.
Publicado: (2019)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Partial chest wall radiation therapy for positive or close surgical margins after modified radical mastectomy for breast cancer without lymph node metastasis
por: Ishibashi, Naoya, et al.
Publicado: (2019)

A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
por: Patel, Krishnan R., et al.
Publicado: (2022)

Bladder mucosa-associated lymphoid tissue lymphoma progressed from chronic cystitis along with a comparative genetic analysis during long-term follow-up: a case report
por: Ishibashi, Naoya, et al.
Publicado: (2021)

Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Effect of Heparinoid Moisturizer on Quality of Life in Patients with Acute Radiation Skin Damage Following Hypofractionated Radiation Therapy After Breast-Conserving Surgery: A Randomized Controlled Study
por: Kawamori, Jiro, et al.
Publicado: (2021)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer
por: Yuen, Jasper, et al.
Publicado: (2008)

Changes in the Ki‐67 labeling index between primary breast cancer and metachronous metastatic axillary lymph node: A retrospective observational study
por: Ishibashi, Naoya, et al.
Publicado: (2018)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
por: Faria, Sergio L, et al.
Publicado: (2006)

Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic
por: Ivanov, Olivera, et al.
Publicado: (2022)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer
por: Oermann, Eric K, et al.
Publicado: (2011)

National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG)
por: Ishibashi, Naoya, et al.
Publicado: (2018)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial
por: Ren, Xiao-Cang, et al.
Publicado: (2016)

Cost‐containment in hypofractionated radiation therapy: a literature review
por: Hunter, Darren, et al.
Publicado: (2018)

Hypofractionated radiation in secretory breast cancer: A case report
por: Tatebe, Ken, et al.
Publicado: (2021)

Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients
por: Saiag, Philippe, et al.
Publicado: (2022)

Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas
por: Elhammali, Adnan, et al.
Publicado: (2015)

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
por: Young, Kristina H., et al.
Publicado: (2016)

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
por: Ciammella, Patrizia, et al.
Publicado: (2013)

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
por: Moore, Assaf, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gunncq3g666htf0257svu6hgko